10-K Filing

Company

IGC Pharma, Inc.

Filed

July 16, 2013

Period of Report

March 31, 2013

Accession Number

0001185185-13-001473

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →